Salt Lake City-Research from the Moran Eye Center, University of Utah School of Medicine, Salt Lake City, showed that low ocular levels of the antioxidants lutein and zeaxanthin could contribute to age-related macular degeneration (AMD).
Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
4DMT presents data from phase 1/2 PRISM clinical trial and outlines 4FRONT phase 3 study
Advancing the optimal diagnosis & treatment of thyroid eye disease
Ripple Therapeutics and AbbVie collaborate in development of RTC-620 for IOP reduction in patients with open-angle glaucoma
Transforming the eye with a new standard for corneal cross-linking